Baseline C-peptide was also an independent inverse risk factor for the progression of DR , with a reduction of 47 % with each 1 pmol/ml increase in C-peptide ( OR 0.53 ; 95 % CI 0.305 , 0.921 ; p = 0.0244 ) .